Signals

/

Biotech & Healthcare

🧪

Biotech & Healthcare

FDA approvals and rejections, clinical trial results, pharma M&A, drug recalls, and funding rounds.

112

signals this month

•

28

sources monitored

•

Updated

2x daily

All

Regulatory

Ransomware

Funding

M&A

Product Launch

Layoffs

Legal

Date

Signal

Sourse

Type

Wockhardt's Zaynich: India's First FDA-Approved New Drug

Business Standard

Comparative Clinical Data on EB613 and Forteo Presented at ENDO 2026

Zumutor Biologics secures $7.3M in Pre-Series B funding

Lilly's new JAK drug shows positive early results in myelofibrosis study

Zilurgisertib trial drug cuts new HO lesions by 99.9%, receives FDA Priority Review

Qurucell CAR-T 'Limcato' Phase 2 Clinical Trial Results Published in Hematology Journal

아시아경제

Takeda Pharmaceutical to lay off 247 Massachusetts employees starting July

Legend Biotech's Single-dose Lymphoma CAR-T Achieves 100% Response at Top Dose

Legend Biotech Achieves Clinical Proof-of-Concept for LB2501 in B-Cell Non-Hodgkin Lymphoma

Celldex's CDX-622 antibody shows mast cell depletion in Phase 1 trial

Lorundrostat shows potential in reducing heart failure risk biomarkers

INCA033989 Shows Positive Results in Myelofibrosis and Essential Thrombocythemia

Kitchen HQ Thermal Insulated Bowls Recalled Due to Fire Hazard

Beekeeper’s Naturals recalls nasal spray due to infection risk

CRISPR gene edit reduces HAE attacks by 87% in Phase 3 trial

Intellia Therapeutics Reports Positive Phase 3 Results for Lonvoguran Ziclumeran

The Manila Times

Lilly's trial drug reduces spleen size and symptoms in myelofibrosis

Over 100 Lymphoma Patients Receive CAR-T Therapy with No Severe CRS

CLL14 Study Confirms Efficacy of Venetoclax-Obinutuzumab Therapy

Disc Medicine reports anemia and light-tolerance gains in clinical studies

Farm Rich Pizza Cheese Crunchers recalled over metal contamination

Market Focus Shifts to Valuation of D&D Pharmatech's DD01 Treatment

아시아경제

Virus-immunotherapy combo linked to longer survival in head and neck cancer

Enliven Therapeutics Reports Positive Phase 1 Data and FDA Alignment on Phase 3 Trial

FDA allows Alpha Tau to complete glioblastoma trial enrollment

Syndax showcases revuforj (revumenib) data at EHA 2026

Genentech R&D layoffs impact top executive with nearly 30 years tenure

Key obesity readouts from ADA 2026 conference

Clinical Trials Arena

Pfizer reports positive Phase IIb trial results for berobenatide

Clinical Trials Arena

Up & Up Baby Wipes Recalled Over Bacterial Contamination

Fox Rio Grande Valley

CNTY-813 Preclinical Data Shows Durable Glucose Control and Immune Evasion

The Manila Times

Ascendis Pharma to Present Rare Endocrine Disease Data at ENDO 2026

Quiver Quantitative

Travere Therapeutics Presents Long-Term Data from Phase 3 DUPLEX Study

Immuneel Therapeutics raises over Rs 100 Cr in Series B funding

London biotech raises $53M to decode immune system with single blood sample

Tech Funding News

Interim data released for BRAF and RAS mCRC therapies at ASCO 2026

Clinical Trials Arena

City of Hope doctor explains Autonomix nerve-targeted cancer pain approach

GSK Prepares for Quantum Threats to Clinical Trial Data Security

Quantum Zeitgeist

Potential Acquisition of Viking Therapeutics and Its Impact

Kardigan plans IPO to fund heart disease drug development

Supreme Court Case on 'Skinny Label' Could Impact Generic Drug Market

Washington Examiner

Concord Biotech Stock Rises on FDA Approval Despite Earnings Decline

Tenaya Therapeutics Reports Interim Data from MyPEAK™-1 Trial

TransCode Therapeutics Completes Phase 1a Trial for TTX-MC138 in Metastatic Cancer

Salmonella Outbreak Linked to Moringa Leaf Powder Dietary Supplements

Cytonics funds osteoarthritis treatment solely with retail investors

ADC Therapeutics Announces LOTIS-5 Phase 3 Trial Results for ZYNLONTA® with Rituximab in DLBCL

Novartis reports Phase III ALIGN results for Vanrafia in IgAN treatment

Spanish biotech Ona Therapeutics raises $87M for ADC development

Insulet to Showcase Omnipod Innovations at ADA Scientific Sessions

Aurobindo Pharma Receives FDA Approval for Tofacitinib Tablets

Wockhardt Receives USFDA Approval for Zaynich Antibiotic

Novartis reports positive Phase III ALIGN trial results for IgAN treatment

Clinical Trials Arena

New Afrezza and FUROSCIX Data Presented at ADA 2026 Scientific Sessions

Biomea Fusion Presents Clinical Data for Icovamenib and Expands BMF-650 Study

Quiver Quantitative

NewLimit raises $435M ahead of first clinical trial

FDA Approves Generic Eribulin Mesylate for Metastatic Breast Cancer

Targeted Oncology

L’Oréal BOLD invests in Olix Pharmaceuticals

Cosmetics Business

Lundbeck Presents New VYEPTI and Bocunebart Migraine Data at AHS Meeting

Autobahn's thyroid hormone mimic shows promise in bipolar depression trial

Sibeprenlimab Preserved Kidney Function Over 12 Months in IgA Nephropathy

Diakonos Oncology Shares Updated DOC1021 GBM Survival Data and Melanoma Study

Paridiprubart shows fewer deaths in acute kidney injury trial

Vertex Presents New ALYFTREK Data at European Cystic Fibrosis Conference

Structure Therapeutics Inc. Reports Positive Phase 2b Data for Aleniglipron

Quiver Quantitative

Phase 2 ZUPREME-1 trial data supports petrelintide for weight management

New diabetes pills show insulin gains and weight-loss potential at ADA

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

The Manila Times

Aleniglipron’s Phase 2b Data Challenges Oral GLP-1 Efficacy Standards

The Clinical Trial Vanguard

Get biotech signals in your CRM

We monitor FDA decisions, trial readouts, funding, and M&A across your target accounts. Signals land in your CRM linked to the right contacts — your reps act on them the same morning.

Book a 15 min call

Dominykas Rukas - Revenanas